ArticleInternal and emergency medicine2024

Aromatase inhibitor-induced bone loss osteosarcopenia in older patients with breast cancer: effects of the RANK/RANKL system's inhibitor denosumab vs. bisphosphonates.

Andrea Casabella et al.PubMed ↗Publisher ↗

No numbers read from the abstract.